Maternal and Neonatal Microbiome

Hadassah Medical Center

Status: Withdrawn

Conditions: Microbiota

Treatments: Other: non invasive sampling

Study type: Observational

Funder types: Other

Identifiers

NCT02891746

Mat-Neo-Micro-HMO-CTIL

Details and patient eligibility

About

The aim of the study is to characterize and monitor the microbiome of premature infants born in the investigators facility until discharge from the NICU. The investigators will also examine the relationship between mode of delivery and the microbiome of the infant, while exploring various possible factors that may affect it. In addition, the investigators will compare the microbiome of premature infants to the microbiome of term babies born at the same time in the same facility.

Sex: All

Ages: Under 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Premature infants ≤ 34 weeks of gestation admitted to the Neonatal Intensive Care Unit at Hadassah University Hospital, Mount Scopus and their mothers.

The control group:

• Neonates ≥ 37 weeks gestation of which 50 were delivered vaginally and 50 by Caesarean section at Hadassah University Hospital, Mount Scopus and their mothers.

Exclusion criteria

• Neonates with congenital anomalies or metabolic conditions.

Trial design

0 participants in 2 patient groups

Premature infants

Description:

premature infants ≤ 34 weeks of gestation

Treatment:

Other: non invasive sampling

Term infants

Description:

neonates ≥ 37 weeks gestation

Treatment:

Other: non invasive sampling